These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1493 related items for PubMed ID: 22448674

  • 1. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
    Oudot A, Oger S, Behr-Roussel D, Caisey S, Bernabé J, Alexandre L, Giuliano F.
    BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674
    [Abstract] [Full Text] [Related]

  • 2. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
    Gacci M, Eardley I, Giuliano F, Hatzichristou D, Kaplan SA, Maggi M, McVary KT, Mirone V, Porst H, Roehrborn CG.
    Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
    [Abstract] [Full Text] [Related]

  • 3. Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction.
    Brock G, Broderick G, Roehrborn CG, Xu L, Wong D, Viktrup L.
    BJU Int; 2013 Nov; 112(7):990-7. PubMed ID: 23937669
    [Abstract] [Full Text] [Related]

  • 4. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
    Miner M, Rosenberg MT, Perelman MA.
    Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
    [Abstract] [Full Text] [Related]

  • 5. Silodosin improves functional consequences of lower urinary tract obstruction secondary to benign prostate hypertrophy, a proof of concept study in the spontaneously hypertensive rat supplemented with testosterone.
    Assaly R, Faugeroux J, Laurin M, Compagnie S, Alexandre L, Giuliano F, Behr-Roussel D.
    BMC Urol; 2020 Aug 27; 20(1):132. PubMed ID: 32854676
    [Abstract] [Full Text] [Related]

  • 6. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
    Antunes AA, Srougi M, Dall'oglio MF, Vicentini F, Paranhos M, Freire GC.
    J Sex Med; 2008 Jul 27; 5(7):1702-7. PubMed ID: 18194186
    [Abstract] [Full Text] [Related]

  • 7. Erectile Dysfunction and Lower Urinary Tract Symptoms.
    De Nunzio C, Roehrborn CG, Andersson KE, McVary KT.
    Eur Urol Focus; 2017 Oct 27; 3(4-5):352-363. PubMed ID: 29191671
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients With Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial.
    Kim SW, Park NC, Lee SW, Yang DY, Park JK, Moon DG, Yang SK, Lee SW, Moon KH, Ahn TY, Kim SW, Park K, Min KS, Ryu JK, Son H, Jung J, Hyun JS.
    J Sex Med; 2017 Aug 27; 14(8):1018-1027. PubMed ID: 28760246
    [Abstract] [Full Text] [Related]

  • 9. Association between erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia in Nigerian men.
    Ikuerowo SO, Akindiji YO, Akinoso OA, Akinlusi FM, Esho JO.
    Urol Int; 2008 Aug 27; 80(3):296-9. PubMed ID: 18480635
    [Abstract] [Full Text] [Related]

  • 10. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A, Robert G, Delongchamps NB, Cornu JN, Saussine C, Haillot O, Devonec M, Fourmarier M, Ballereau C, Lukacs B, Dumonceau O, Azzouzi AR, Faix A, Desgrandchamps F, de la Taille A, Comité des troubles mictionnels de l’homme de l’association française d’urologie.
    Prog Urol; 2012 Dec 27; 22(16):977-88. PubMed ID: 23178093
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.
    Porst H, Kim ED, Casabé AR, Mirone V, Secrest RJ, Xu L, Sundin DP, Viktrup L, LVHJ study team.
    Eur Urol; 2011 Nov 27; 60(5):1105-13. PubMed ID: 21871706
    [Abstract] [Full Text] [Related]

  • 12. Tadalafil - a therapeutic option in the management of BPH-LUTS.
    Carson CC, Rosenberg M, Kissel J, Wong DG.
    Int J Clin Pract; 2014 Jan 27; 68(1):94-103. PubMed ID: 24341303
    [Abstract] [Full Text] [Related]

  • 13. Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment.
    Roehrborn CG, Egan KB, Miner MM, Ni X, Wong DG, Rosen RC.
    BJU Int; 2016 Jul 27; 118(1):153-60. PubMed ID: 26765325
    [Abstract] [Full Text] [Related]

  • 14. Association of lower urinary tract symptom/benign prostatic hyperplasia measures with international index of erectile function 5 in middle-aged policemen of Korea and the role of metabolic syndrome and testosterone in their relationship.
    Lee JH, Kwon H, Park YW.
    Urology; 2013 Nov 27; 82(5):1008-12. PubMed ID: 24041675
    [Abstract] [Full Text] [Related]

  • 15. [Sexual dysfunctions linked with prostatic diseases].
    Rouprêt M, Seisen T, De La Taille A, Desgrandchamps F.
    Prog Urol; 2012 Jun 27; 22 Suppl 1():S14-20. PubMed ID: 22770495
    [Abstract] [Full Text] [Related]

  • 16. Insulin resistance is an independent predictor of severe lower urinary tract symptoms and of erectile dysfunction: results from a cross-sectional study.
    Russo GI, Cimino S, Fragalà E, Privitera S, La Vignera S, Condorelli R, Calogero AE, Castelli T, Favilla V, Morgia G.
    J Sex Med; 2014 Aug 27; 11(8):2074-82. PubMed ID: 24836928
    [Abstract] [Full Text] [Related]

  • 17. Sexual function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride.
    Glina S, Roehrborn CG, Esen A, Plekhanov A, Sorsaburu S, Henneges C, Büttner H, Viktrup L.
    J Sex Med; 2015 Jan 27; 12(1):129-38. PubMed ID: 25353053
    [Abstract] [Full Text] [Related]

  • 18. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function.
    Lowe FC.
    BJU Int; 2005 Jun 27; 95 Suppl 4():12-8. PubMed ID: 15871731
    [Abstract] [Full Text] [Related]

  • 19. Re: a new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
    Atala A.
    J Urol; 2013 Aug 27; 190(2):807. PubMed ID: 23845375
    [No Abstract] [Full Text] [Related]

  • 20. Alpha-adrenoceptors are a common denominator in the pathophysiology of erectile function and BPH/LUTS--implications for clinical practice.
    Yassin A, Saad F, Hoesl CE, Traish AM, Hammadeh M, Shabsigh R.
    Andrologia; 2006 Feb 27; 38(1):1-12. PubMed ID: 16420236
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 75.